Growing community of inventors

New London, CT, United States of America

Christopher Lowell Autry

Average Co-Inventor Count = 6.43

ph-index = 4

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 67

Christopher Lowell AutryMichael Luzzio (5 patents)Christopher Lowell AutryMatthew Merrill Hayward (4 patents)Christopher Lowell AutrySamit Kumar Bhattacharya (4 patents)Christopher Lowell AutryKevin Daniel Freeman-Cook (4 patents)Christopher Lowell AutryJun Xiao (4 patents)Christopher Lowell AutryKendra Louise Nelson (4 patents)Christopher Lowell AutryXumiao Zhao (4 patents)Christopher Lowell AutryCatherine Angela Hulford (4 patents)Christopher Lowell AutryMatthew Arnold Marx (1 patent)Christopher Lowell AutryJun Xiao (1 patent)Christopher Lowell AutryChristopher Lowell Autry (5 patents)Michael LuzzioMichael Luzzio (53 patents)Matthew Merrill HaywardMatthew Merrill Hayward (32 patents)Samit Kumar BhattacharyaSamit Kumar Bhattacharya (19 patents)Kevin Daniel Freeman-CookKevin Daniel Freeman-Cook (15 patents)Jun XiaoJun Xiao (7 patents)Kendra Louise NelsonKendra Louise Nelson (5 patents)Xumiao ZhaoXumiao Zhao (4 patents)Catherine Angela HulfordCatherine Angela Hulford (4 patents)Matthew Arnold MarxMatthew Arnold Marx (7 patents)Jun XiaoJun Xiao (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Pfizer Corporation (3 from 4,459 patents)

2. Other (1 from 833,002 patents)

3. Agouron Pharmaceuticals, Inc. (1 from 174 patents)


5 patents:

1. 10450297 - Sulfonyl amide derivatives for the treatment of abnormal cell growth

2. 8440822 - Sulfonyl amide derivatives for the treatment of abnormal cell growth

3. 8247411 - Sulfonyl amide derivatives for the treatment of abnormal cell growth

4. 7928109 - Sulfonyl amide derivatives for the treatment of abnormal cell growth

5. 6995171 - Bicyclic pyrimidine and pyrimidine derivatives useful as anticancer agents

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/22/2026
Loading…